Harmony Biosciences Holdings (HRMY) Price & Analysis

Compare

332 Followers

HRMY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$26.47 - $41.61

Previous CloseN/A

Volume87.33K

Average Volume (3M)573.45K

Market Cap

$2.14B

Enterprise Value$1.49B

Total Cash (Recent Filing)$565.27M

Total Debt (Recent Filing)$172.09M

Price to Earnings (P/E)12.0

Beta1.54

Next Earnings

Nov 04, 2025

EPS Estimate

0.74

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.68

Shares Outstanding57,532,600

10 Day Avg. Volume457,438

30 Day Avg. Volume573,453

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.70

Enterprise Value/Revenue1.93

Enterprise Value/Gross Profit2.46

Enterprise Value/Ebitda5.62

Forecast

1Y Price Target

$52.29

Price Target Upside40.68% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

Bulls Say, Bears Say

Bulls Say

Market PotentialThe potential market for ZYN-002 is large, with a total addressable market of over $2 billion and no FDA approved treatments currently available.

Pipeline DevelopmentThe upcoming data readout for ZYN-002 in Fragile X Syndrome is an important milestone for Harmony Biosciences as it could validate the company's strategy of building its pipeline.

Revenue GrowthWAKIX continues to deliver resilient growth, with 16% year-over-year revenue expansion and steady prescriber penetration across both REMS and non-REMS segments.

Bears Say

Earnings MissHRMY reported a top-line miss, with Wakix revenue of $200.5mn below estimates.

Placebo ResponseThere is a risk of high placebo response impacting the success of ZYN-002 in Fragile X Syndrome.

Harmony Biosciences Holdings News

3 Best Stocks to Buy Now, 8/6/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

22d ago

HRMY

SNDX

Harmony Biosciences backs FY25 revenue view $820M-$860M, consensus $843.63M

The company said, “Reaffirming full year 2025 net product revenue of $820 million to $860 million.” Published first...

23d ago

HRMY

Harmony Biosciences reports Q2 adjusted EPS 92c, consensus 96c

Reports Q2 revenue $200.49M, consensus $204.12M. “The approximately 80,000 U.S. families in the Fragile X community have been...

23d ago

HRMY

3 Best Stocks to Buy Now, 7/29/2025, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below...

30d ago

DNTH

HRMY

Harmony Biosciences: Buy Rating Affirmed on Strong Growth Prospects and Strategic Advancements

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Harmony Biosciences Holdings today and set a price...

22d ago

HRMY

Harmony Biosciences Earnings Call Highlights Growth and Innovation

Harmony Biosciences Holdings, Inc. (($HRMY)) has held its Q2 earnings call. Read on for the main highlights of...

22d ago

HRMY

Harmony Biosciences Holdings: Strong Patient Growth and Promising Pipeline Support Buy Rating

Analyst Ami Fadia of Needham maintained a Buy rating on Harmony Biosciences Holdings, retaining the price target of...

23d ago

HRMY

Harmony Biosciences Holdings: Promising Growth Trajectory with Strong Leadership and Robust Pipeline Supports Buy Rating

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings,...

1M ago

HRMY

Harmony Biosciences initiated with a Buy at Truist

Truist initiated coverage of Harmony Biosciences (HRMY) with a Buy rating and $48 price target Truist sees unrealized...

1M ago

HRMY

Buy Rating Reaffirmed for Harmony Biosciences Amid Promising Orexin-2 Developments and Takeda’s Phase 3 Success

Analyst Patrick Trucchio of H.C. Wainwright reiterated a Buy rating on Harmony Biosciences Holdings, retaining the price target...

1M ago

HRMY

Harmony Biosciences price target raised to $55 from $54 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Harmony Biosciences (HRMY) to $55 from $54 and keeps a...

2M ago

HRMY

Harmony Biosciences resumed with a Neutral at Goldman Sachs

Goldman Sachs analyst Corinne Johnson resumed coverage of Harmony Biosciences (HRMY) with a Neutral rating and $33 price...

2M ago

HRMY

Harmony Biosciences Reveals Promising Preclinical Data for BP1.15205

Harmony Biosciences Holdings ( ($HRMY) ) just unveiled an update. On June 11, 2025, Harmony Biosciences announced new...

3M ago

HRMY

Harmony Biosciences presents preclinical data for BP1.15205

Harmony Biosciences (HRMY) announced the presentation of preclinical pharmacological effect data for BP1.15205, an investigational, highly potent, and...

3M ago

HRMY

HRMY FAQ

What was Harmony Biosciences Holdings’s price range in the past 12 months?

Harmony Biosciences Holdings lowest stock price was $26.47 and its highest was $41.61 in the past 12 months.

What is Harmony Biosciences Holdings’s market cap?

Harmony Biosciences Holdings’s market cap is $2.14B.

When is Harmony Biosciences Holdings’s upcoming earnings report date?

Harmony Biosciences Holdings’s upcoming earnings report date is Nov 04, 2025 which is in 68 days.

How were Harmony Biosciences Holdings’s earnings last quarter?

Harmony Biosciences Holdings released its earnings results on Jul 31, 2025. The company reported $0.68 earnings per share for the quarter, missing the consensus estimate of $0.705 by -$0.025.

Is Harmony Biosciences Holdings overvalued?

According to Wall Street analysts Harmony Biosciences Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Harmony Biosciences Holdings pay dividends?

Harmony Biosciences Holdings does not currently pay dividends.

What is Harmony Biosciences Holdings’s EPS estimate?

Harmony Biosciences Holdings’s EPS estimate is 0.74.

How many shares outstanding does Harmony Biosciences Holdings have?

Harmony Biosciences Holdings has 57,532,600 shares outstanding.

What happened to Harmony Biosciences Holdings’s price movement after its last earnings report?

Harmony Biosciences Holdings reported an EPS of $0.68 in its last earnings report, missing expectations of $0.705. Following the earnings report the stock price went down -0.846%.

Which hedge fund is a major shareholder of Harmony Biosciences Holdings?

Currently, no hedge funds are holding shares in HRMY

Harmony Biosciences Holdings Stock Smart Score

Outperform

Fundamentals

Return on Equity

27.58%

Trailing 12-Months

Asset Growth

29.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc. is a pharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological disorders. The company is primarily engaged in the healthcare sector, with its core product being WAKIX (pitolisant), a novel treatment for excessive daytime sleepiness in adults with narcolepsy.

Harmony Biosciences Holdings (HRMY) Earnings & Revenues

Historic Earnings Reports

HRMY Company Deck

HRMY Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call reflects a strong performance by Harmony Biosciences with significant revenue growth and advancements in their clinical pipeline. The company has a robust pipeline and financial health, although there are some concerns about trade inventory reductions and potential expenses. Overall, the positive aspects significantly outweigh the challenges.View all HRMY earnings summaries

HRMY Stock 12 Month Forecast

Average Price Target

$52.29

▲(40.68% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","71":"$71","38.75":"$38.8","49.5":"$49.5","60.25":"$60.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$70.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$52.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$33.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,38.75,49.5,60.25,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.4,37.138461538461534,39.87692307692308,42.61538461538461,45.35384615384615,48.09230769230769,50.83076923076923,53.56923076923077,56.30769230769231,59.04615384615384,61.784615384615385,64.52307692307693,67.26153846153846,{"y":70,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.4,35.776153846153846,37.152307692307694,38.528461538461535,39.90461538461538,41.28076923076923,42.65692307692308,44.03307692307692,45.40923076923077,46.785384615384615,48.16153846153846,49.53769230769231,50.91384615384615,{"y":52.29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,34.4,34.29230769230769,34.184615384615384,34.07692307692307,33.96923076923077,33.86153846153846,33.753846153846155,33.646153846153844,33.53846153846154,33.43076923076923,33.323076923076925,33.215384615384615,33.10769230769231,{"y":33,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":32.72,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.98,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.24,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.08,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.13,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.41,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.85,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.03,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >